• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

辐射暴露对切尔诺贝利甲状腺癌复发的风险没有显著影响。

Radiation exposure does not significantly contribute to the risk of recurrence of Chernobyl thyroid cancer.

机构信息

Department of Radiosurgery, Medical Radiological Research Center of Russian Academy of Medical Sciences, Obninsk 249036, Russian Federation.

出版信息

J Clin Endocrinol Metab. 2011 Feb;96(2):385-93. doi: 10.1210/jc.2010-1634. Epub 2010 Nov 17.

DOI:10.1210/jc.2010-1634
PMID:21084394
Abstract

CONTEXT

Papillary thyroid carcinoma (PTC) in patients exposed to environmental radioiodine after the Chernobyl accident is thought to have a relatively aggressive clinical course. Long-term results of treatment are not well known, especially in comparison with sporadic PTC.

OBJECTIVE

The determination of risk factors for PTC recurrence in a controlled for baseline factors group of patients with radiation-related and sporadic PTC.

DESIGN

Retrospective cohort study involving patients treated for PTC and followed-up in 1991-2008. Risk factors were assessed by stratified analysis using the proportional hazard model.

SETTING

Referral center-based.

PATIENTS

A total of 497 patients were enrolled. Patients exposed to radioiodine were 172 individuals with reconstructed individual radiation thyroid doses ranging 51-3170 mGy. Patients with sporadic PTC included 325 individuals matched to exposed patients for sex, age ± 5 yr and time to treatment ± 2 yr.

MAIN OUTCOME MEASURE

Cancer recurrence.

RESULTS

Nodal disease increased the recurrence rate (HR = 5.21; 95% CI = 1.63-16.7) while the presence of tumor capsule (HR = 0.17; 95% CI = 0.06-0.45) and, particularly, treatment according to the Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer significantly reduced it (HR = 0.16; 95% CI = 0.06-0.42). None of the tested variables interacted with radiation factor.

CONCLUSIONS

PTC developing after internal exposure to radioiodine does not display specific risk factors for recurrence different from those in sporadic PTC. Common treatment approaches for patients with PTC should be recommended regardless of a history of radiation exposure.

摘要

背景

切尔诺贝利事故后暴露于环境放射性碘的患者的甲状腺乳头状癌(PTC)被认为具有相对侵袭性的临床病程。长期治疗结果尚不清楚,特别是与散发性 PTC 相比。

目的

在基线因素控制的基础上,确定放射性和散发性 PTC 相关患者的 PTC 复发的危险因素。

设计

回顾性队列研究,纳入 1991-2008 年接受 PTC 治疗并随访的患者。使用比例风险模型进行分层分析评估危险因素。

设置

基于转诊中心。

患者

共纳入 497 例患者。接受放射性碘治疗的患者为 172 例,个体重建的甲状腺辐射剂量范围为 51-3170 mGy。散发性 PTC 患者包括 325 例与暴露患者匹配的个体,性别、年龄 ± 5 岁和治疗时间 ± 2 岁。

主要观察指标

癌症复发。

结果

淋巴结疾病增加了复发率(HR = 5.21;95%CI = 1.63-16.7),而肿瘤包膜的存在(HR = 0.17;95%CI = 0.06-0.45),特别是根据修订后的美国甲状腺协会甲状腺结节和分化型甲状腺癌管理指南进行治疗,显著降低了复发率(HR = 0.16;95%CI = 0.06-0.42)。测试的变量均未与辐射因素相互作用。

结论

放射性碘内暴露后发生的 PTC 复发没有不同于散发性 PTC 的特定危险因素。无论是否有辐射暴露史,都应推荐用于 PTC 患者的常规治疗方法。

相似文献

1
Radiation exposure does not significantly contribute to the risk of recurrence of Chernobyl thyroid cancer.辐射暴露对切尔诺贝利甲状腺癌复发的风险没有显著影响。
J Clin Endocrinol Metab. 2011 Feb;96(2):385-93. doi: 10.1210/jc.2010-1634. Epub 2010 Nov 17.
2
Radiation induced thyroid cancer: fundamental and applied aspects.辐射诱发的甲状腺癌:基础与应用方面
Exp Oncol. 2010 Sep;32(3):200-4.
3
Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.乳头状和滤泡状甲状腺癌的病理肿瘤-淋巴结-转移(pTNM)分期:700例患者的回顾性分析
J Clin Endocrinol Metab. 1997 Nov;82(11):3553-62. doi: 10.1210/jcem.82.11.4373.
4
Treatment for microcarcinoma of the thyroid--clinical experience.甲状腺微小癌的治疗——临床经验
Clin Nucl Med. 2007 Apr;32(4):279-81. doi: 10.1097/01.rlu.0000257272.90126.3d.
5
Influence of previous radiation exposure on pathologic features and clinical outcome in patients with thyroid cancer.既往辐射暴露对甲状腺癌患者病理特征及临床结局的影响。
Arch Otolaryngol Head Neck Surg. 2009 Apr;135(4):355-9. doi: 10.1001/archoto.2009.13.
6
Clinical presentation and clinical outcomes in Chernobyl-related paediatric thyroid cancers: what do we know now? What can we expect in the future?切尔诺贝利相关儿童甲状腺癌的临床表现和临床结局:我们现在知道了什么?我们未来能期待什么?
Clin Oncol (R Coll Radiol). 2011 May;23(4):268-75. doi: 10.1016/j.clon.2011.01.178. Epub 2011 Feb 15.
7
Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.甲状腺微小乳头状癌的癌症复发:对231例患者进行12年随访的多因素分析
Minerva Endocrinol. 2013 Sep;38(3):269-79.
8
Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.侵袭性甲状腺乳头状癌的变异型:43738 例患者中的发病率、特征和生存预测因素。
Ann Surg Oncol. 2012 Jun;19(6):1874-80. doi: 10.1245/s10434-011-2129-x. Epub 2011 Nov 8.
9
Improving postoperative recurrence rates for carcinoma of the thyroid gland.提高甲状腺癌术后复发率。
Surg Gynecol Obstet. 1989 Nov;169(5):429-34.
10
The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.手术、放射性碘及外照射放疗对分化型甲状腺癌患者临床结局的影响。
Cancer. 1998 Jan 15;82(2):375-88.

引用本文的文献

1
Radiation-Related Thyroid Cancer.放射性甲状腺癌。
Endocr Rev. 2024 Jan 4;45(1):1-29. doi: 10.1210/endrev/bnad022.
2
Chernobyl-related thyroid cancer.切尔诺贝利相关的甲状腺癌。
Eur J Epidemiol. 2018 Apr;33(4):429-431. doi: 10.1007/s10654-018-0391-y. Epub 2018 Apr 7.
3
Clinical significance of miR-34a expression in thyroid diseases - an F-FDG PET-CT study.甲状腺疾病中miR-34a表达的临床意义——一项F-FDG PET-CT研究
Cancer Manag Res. 2017 Dec 15;9:903-913. doi: 10.2147/CMAR.S143110. eCollection 2017.
4
Lessons from Fukushima: Latest Findings of Thyroid Cancer After the Fukushima Nuclear Power Plant Accident.福岛的教训:福岛核事故后甲状腺癌的最新发现。
Thyroid. 2018 Jan;28(1):11-22. doi: 10.1089/thy.2017.0283. Epub 2017 Dec 1.
5
Meeting report: the 5th International expert symposium in Fukushima on radiation and health.会议报告:第五届福岛辐射与健康国际专家研讨会
Environ Health. 2017 Jan 18;16(1):3. doi: 10.1186/s12940-017-0211-y.
6
Previous External Beam Radiation Treatment Exposure Does Not Confer Worse Outcome for Patients with Differentiated Thyroid Cancer.既往接受外照射放疗不会使分化型甲状腺癌患者的预后更差。
Thyroid. 2017 Mar;27(3):412-417. doi: 10.1089/thy.2016.0303. Epub 2017 Feb 16.
7
Radiation-Induced Differentiated Thyroid Cancer Is Associated with Improved Overall Survival but Not Thyroid Cancer-Specific Mortality or Disease-Free Survival.放射性诱导的分化型甲状腺癌与总体生存率提高相关,但与甲状腺癌特异性死亡率或无病生存率无关。
Thyroid. 2016 Aug;26(8):1053-60. doi: 10.1089/thy.2015.0634.
8
Expression profiles of pivotal microRNAs and targets in thyroid papillary carcinoma: an analysis of The Cancer Genome Atlas.甲状腺乳头状癌中关键微小RNA及其靶标的表达谱:来自癌症基因组图谱的分析
Onco Targets Ther. 2015 Aug 26;8:2271-7. doi: 10.2147/OTT.S85753. eCollection 2015.
9
Clinical experiences with radiation induced thyroid cancer after chernobyl.切尔诺贝利核事故后辐射诱发甲状腺癌的临床经验。
Genes (Basel). 2011 May 31;2(2):374-83. doi: 10.3390/genes2020374.
10
Long-term prognosis of differentiated thyroid cancer with lung metastasis in Korea and its prognostic factors.韩国分化型甲状腺癌肺转移的长期预后及其预后因素。
Thyroid. 2014 Feb;24(2):277-86. doi: 10.1089/thy.2012.0654. Epub 2013 Sep 11.